SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-017669
Filing Date
2022-05-04
Accepted
2022-05-04 07:25:09
Documents
104
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20220331.htm   iXBRL 10-Q 3792391
2 EX-10.4 hznp-ex104_796.htm EX-10.4 13932
3 EX-31.1 hznp-ex311_625.htm EX-31.1 16076
4 EX-31.2 hznp-ex312_624.htm EX-31.2 15829
5 EX-32.1 hznp-ex321_622.htm EX-32.1 8962
6 EX-32.2 hznp-ex322_623.htm EX-32.2 8983
  Complete submission text file 0001564590-22-017669.txt   14788858

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA hznp-20220331.xsd EX-101.SCH 99911
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20220331_cal.xml EX-101.CAL 88429
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20220331_def.xml EX-101.DEF 380210
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20220331_lab.xml EX-101.LAB 694438
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20220331_pre.xml EX-101.PRE 596113
98 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20220331_htm.xml XML 2957698
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 22889826
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences